Sterile Injectables Market, By Molecule Type, By Drug Type, By Disease Indication, By Route of Administration (Intravenous, Intramuscular, Subcutaneous, and Others), By Geography

Description

Global sterile injectables market is estimated to be valued at USD 586.1 Bn in 2024 and is expected to reach USD 984.1 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.7% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 586.1 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	7.70%	2031 Value Projection:	US$ 984.1 Bn

Figure. Sterile Injectables Market Share (%), By Region 2024

Global sterile injectables market growth is driven by rising incidence of chronic diseases along with growing geriatric population worldwide who are more susceptible to such diseases. Sterile injectables are used in therapeutic areas like oncology, autoimmune diseases, hematology, ophthalmology, anesthesia, and others. Moreover, rising demand for biologics and affordability of these drugs can drive the market growth. However, stringent regulatory norms associated with sterile injectables production can hamper the market growth during the forecast period.

Market Dynamics:

Global sterile injectables market growth is driven by growing incidence of cancer and other chronic diseases globally. Growing geriatric population prone to chronic medical conditions can also boost demand for sterile injectables. Moreover, rising popularity of biologics over conventional drugs due to superior efficacy can offer new market growth opportunities. However, high production costs associated with sterile injectables due to stringent quality control standards imposed by regulatory authorities can hamper the market growth. Product recalls owing to contamination issues during manufacturing can hamper the market growth. Ongoing R&D activities for developing effective biosimilars can offer market growth opportunities in the near future.

Key Features of the Study:

This report provides in-depth analysis of the global sterile injectables market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook and competitive strategies adopted by key players.
It profiles key players in the global sterile injectables market based on the following parameters - company highlights, products portfolio, key highlights, financial performance and strategies.
Key companies covered as a part of this study include Pfizer Inc., Baxter International Inc., Abbott Laboratories and GlaxoSmithKline plc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion and marketing tactics.
Global sterile injectables market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sterile injectables market

Detailed Segmentation-

By Molecule Type
- Large Molecules
- Small Molecule
By Drug Type
- Monoclonal Antibodies
- Cytokines
- Insulin
- Peptide Hormones
- Blood Factors
- Vaccines
- Immunoglobulins
- Peptide Antibiotics
- Others
By Disease Indication
- Cancer
- Diabetes
- Cardiovascular Disorders
- Musculoskeletal Disorders
- CNS disorders
- Infectious Disorders
- Others
By Route of Administration
- Intravenous (IV)
- Intramuscular (IM)
- Subcutaneous (SC)
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Pfizer Inc.
- Merck & Co., Inc.
- Johnson & Johnson
- Baxter International Inc.
- Novartis AG
- Sanofi S.A.
- GlaxoSmithKline plc (GSK)
- AstraZeneca PLC
- Gilead Sciences, Inc.
- Amgen Inc.
- AbbVie Inc.
- Teva Pharmaceutical Industries Ltd.
- Bayer AG
- Fresenius SE & Co. KGaA (Fresenius Kabi)
- Becton, Dickinson and Company (BD)
- Hoffmann-La Roche Ltd
- Eli Lilly and Company

Product Code: CMI201

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Molecule Type
- Market Snapshot, By Drug Type
- Market Snapshot, By Disease Indication
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Sterile Injectables Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Sterile Injectables Market, By Molecule Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Large Molecules
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Small Molecule
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Sterile Injectables Market, By Drug Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Monoclonal Antibodies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cytokines
- Mammography
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Insulin
- Chest X-ray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Peptide Hormones
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Blood Factors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Vaccines
- Mammography
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Immunoglobulins
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Peptide Antibiotics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Sterile Injectables Market, By Disease Indication, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Diabetes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cardiovascular Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Musculoskeletal Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
CNS disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Infectious Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Sterile Injectables Market, By Route of Administration, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Intravenous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Intramuscular
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Subcutaneous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Sterile Injectables Market, By Distribution Channel, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

10. Global Sterile Injectables Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
Asia Pacific
Middle East

11. Competitive Landscape

Company Profiles
- Pfizer Inc.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck & Co., Inc.
- Johnson & Johnson
- Baxter International Inc.
- Novartis AG
- Sanofi S.A.
- GlaxoSmithKline plc (GSK)
- AstraZeneca PLC
- Gilead Sciences, Inc.
- Amgen Inc.
- AbbVie Inc.
- Teva Pharmaceutical Industries Ltd.
- Bayer AG
- Fresenius SE & Co. KGaA (Fresenius Kabi)
- Becton, Dickinson and Company (BD)
- F. Hoffmann-La Roche Ltd
- Eli Lilly and Company

12. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

13. References and Research Methodology

References
Research Methodology
About us and Sales Contact